Proactive Investors - Run By Investors For Investors

Buds & Duds: iAnthus Capital rallies after closing its acquisition of MPX Bioceutical

Cronos Group declined following a downgrade to Hold by GMP Securities while Aphria fell after its board rejected Green Growth's hostile takeover bid
A pot plant
After its cannabis deal, iAnthus now has operations in 11 US states

Cannabis stocks in the US and Canada declined Wednesday, trading in the same direction as the S&P 500 Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 4.4% to 283.21. The S&P/TSX Composite Index was up 0.2%.


iAnthus Capital Holdings Inc (OTCMKTS:ITHUF) (CSE: IAN) climbed 5.1% to US$5.58 after the New York cannabis company announced the closing of its acquisition of MPX Bioceutical Corp (OTCMKTS:MPXEF) (CSE:MPX).  

Under the deal, investors received 0.1673 common share of iAnthus for each MPX share held, representing a premium of almost 31% based on the closing price of iAnthus and Toronto-based MPX on October 17, iAnthus said in a statement.

The combined company now has operations in 11 US states, allowing it to operate 63 retail operations and 15 cultivation or processing facilities, according to iAnthus.

iAnthus was up 5.6% to C$7.37 in Canadian trading.


Aphria Inc (NYSE:APHA) (TSE:APHA ) dropped 7.5% to US$9.91 in New York trading after announcing that its board has rejected the hostile bid from Green Growth Brands Inc (OTCMKTS:GGBXF) (CSE:GGB).

The hostile bid reflects a 23% discounto the cannabis company’s share price, Aphria said in a statement. It cited the 20-day volume-weighted average price of Green Growth’s shares immediately before the company announced its offer.

Acceptance of the offer would result in Aphria’s shareholders giving Green Growth shareholders a 36% interest in Aphria in exchange for shares in a company with limited experience in the cannabis industry, Aphria said in a statement.

Afria was down 6.9% to C$13.10 in Canadian trading. Green Growth fell 4.9% to US$4.26 on the OTC Markets and decreased 4.4% to C$5.61

Cronos Group Inc (NASDAQ:CRON) (TSE:CRON) dropped 6.9% to US$20.33 after GMP Securities LP reportedly downgraded the Toronto-based cannabis company to Hold from Buy and maintained its price target at C$24. 

In December, the tobacco giant Altria Group Inc (NYSE:MO) agreed to make a C$2.4 billion equity investment in Cronos.

Cronos fell 7.1% to C$26.66 in Canadian trading.

Contact Dennis Fitzgerald at [email protected]

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use